| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
BAY-27-9955 manufacturers
- BAY-27-9955
-
-
2026-05-11
- CAS:202855-56-9
- Purity:
- Supply Ability: 10g
|
| | BAY-27-9955 Basic information |
| Product Name: | BAY-27-9955 | | Synonyms: | BAY-27-9955;BAY279955,BAY 27 9955;[1,1'-Biphenyl]-2-methanol, 4'-fluoro-α-methyl-3,5-bis(1-methylethyl)-6-propyl-, (+)-;3,5-Diisopropyl-2-(1-hydroxyethyl)-6-propyl-4'-fluoro-1,1'-biphenyl | | CAS: | 202855-56-9 | | MF: | C23H31FO | | MW: | 342.5 | | EINECS: | | | Product Categories: | | | Mol File: | 202855-56-9.mol |  |
| | BAY-27-9955 Chemical Properties |
| Boiling point | 446.1±45.0 °C(Predicted) | | density | 1.008±0.06 g/cm3(Predicted) | | pka | 14.57±0.20(Predicted) |
| | BAY-27-9955 Usage And Synthesis |
| Uses | BAY-27-9955 is an orally active non-peptide glucagon receptor antagonist. Bay 27-9955 competitively blocks the interaction of glucagon with the human glucagonreceptor at an IC50 value of 110 nM. BAY-27-9955 can be used for the study of type 2 diabetes[1]. | | References | [1] K F Petersen, et al. Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia. 2001 Nov;44(11):2018-24. DOI:10.1007/s001250100006 |
| | BAY-27-9955 Preparation Products And Raw materials |
|